Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Why standard dosing ranges exist The 300-500mcg daily range did not appear arbitrarily
Jiang L, Jia M, Wei X, et al
The substantial weight reduction observed with tirzepatide monotherapy (15-21% body weight in clinical trials) suggests that any perceived benefits likely reflect tirzepatide's pharmacological effects rather than synergistic action
Injectable Dose: 0.1 to 0.2 mg three times weekly Topical Option: Apply serum to target areas twice daily Combined Approach: Injectable 3x weekly plus topical to specific areas Duration: 8 to 12 weeks, can extend longer due to favorable safety profile The timing of GHK-Cu introduction matters for maximum benefit
